BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 33752746)

  • 1. DNA methylation biomarker for cumulative lead exposure is associated with Parkinson's disease.
    Paul KC; Horvath S; Del Rosario I; Bronstein JM; Ritz B
    Clin Epigenetics; 2021 Mar; 13(1):59. PubMed ID: 33752746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood DNA methylation biomarkers of cumulative lead exposure in adults.
    Colicino E; Just A; Kioumourtzoglou MA; Vokonas P; Cardenas A; Sparrow D; Weisskopf M; Nie LH; Hu H; Schwartz JD; Wright RO; Baccarelli AA
    J Expo Sci Environ Epidemiol; 2021 Feb; 31(1):108-116. PubMed ID: 31636367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated hematopoietic mitotic aging measured by DNA methylation, blood cell lineage, and Parkinson's disease.
    Paul KC; Binder AM; Horvath S; Kusters C; Yan Q; Rosario ID; Yu Y; Bronstein J; Ritz B
    BMC Genomics; 2021 Sep; 22(1):696. PubMed ID: 34565328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Methylation Age Acceleration Is Not Associated with Age of Onset in Parkinson's Disease.
    Gaare JJ; Brügger K; Nido GS; Tzoulis C
    Mov Disord; 2023 Nov; 38(11):2064-2071. PubMed ID: 37551021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative relationships of FAM50B and PTCHD3 methylation with reduced intelligence quotients in school aged children exposed to lead: Evidence from epidemiological and in vitro studies.
    Wan C; Ma H; Liu J; Liu F; Liu J; Dong G; Zeng X; Li D; Yu Z; Wang X; Li J; Zhang G
    Sci Total Environ; 2024 Jan; 907():167976. PubMed ID: 37866607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation and pesticide exposure influence blood DNA methylation signatures in females with early-stage Parkinson's disease.
    Schaffner SL; Casazza W; Artaud F; Konwar C; Merrill SM; Domenighetti C; Schulze-Hentrich JM; Lesage S; Brice A; Corvol JC; Mostafavi S; Dennis JK; Elbaz A; Kobor MS;
    NPJ Parkinsons Dis; 2024 May; 10(1):98. PubMed ID: 38714693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 21st century headache: mapping new territory.
    Goadsby PJ; Lantéri-Minet M; Michel MC; Peres M; Shibata M; Straube A; Wijeratne T; Ebel-Bitoun C; Constantin L; Hitier S
    J Headache Pain; 2021 Apr; 22(1):19. PubMed ID: 33794761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Death of the Hypothesis: Researchers Do Not Report A Priori Beliefs in General Medicine Journals.
    Chaitoff A; Zheutlin A; Roy S; Niforatos JD
    J Gen Intern Med; 2022 Feb; 37(3):695-696. PubMed ID: 33791933
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of Physical Activity and
    Kim R; Park S; Yoo D; Jun JS; Jeon B
    Neurology; 2021 May; 96(19):e2429-e2437. PubMed ID: 33790041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cluster headache pathophysiology - insights from current and emerging treatments.
    Wei DY; Goadsby PJ
    Nat Rev Neurol; 2021 May; 17(5):308-324. PubMed ID: 33782592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion-like C-Terminal Domain of TDP-43 and α-Synuclein Interact Synergistically to Generate Neurotoxic Hybrid Fibrils.
    Dhakal S; Wyant CE; George HE; Morgan SE; Rangachari V
    J Mol Biol; 2021 May; 433(10):166953. PubMed ID: 33771571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative proteome analyses highlight several exercise-like responses of mouse sciatic nerve after IP injection of irisin.
    Momenzadeh S; Zamani S; Dehghan F; Barreiro C; Jami MS
    Eur J Neurosci; 2021 May; 53(10):3263-3278. PubMed ID: 33759230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the contribution of the chemical exposome to neurodegenerative disease.
    Lefèvre-Arbogast S; Chaker J; Mercier F; Barouki R; Coumoul X; Miller GW; David A; Samieri C
    Nat Neurosci; 2024 May; 27(5):812-821. PubMed ID: 38684891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trace Elements in Alzheimer's Disease and Dementia: The Current State of Knowledge.
    Tyczyńska M; Gędek M; Brachet A; Stręk W; Flieger J; Teresiński G; Baj J
    J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking environmental risk factors with epigenetic mechanisms in Parkinson's disease.
    Tsalenchuk M; Gentleman SM; Marzi SJ
    NPJ Parkinsons Dis; 2023 Aug; 9(1):123. PubMed ID: 37626097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin can improve spinal cord injury by inhibiting DNA methylation.
    Zhou Y; Zhang Y; Botchway BOA; Wang X; Liu X
    Mol Cell Biochem; 2024 Feb; 479(2):351-362. PubMed ID: 37076656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolutionary Implications of Environmental Toxicant Exposure.
    Bolognesi G; Bacalini MG; Pirazzini C; Garagnani P; Giuliani C
    Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36551846
    [No Abstract]   [Full Text] [Related]  

  • 18. Epigenetic Biomarkers of Lead Exposure and Cardiovascular Disease: Prospective Evidence in the Strong Heart Study.
    Lieberman-Cribbin W; Domingo-Relloso A; Navas-Acien A; Cole S; Haack K; Umans J; Tellez-Plaza M; Colicino E; Baccarelli AA; Gao X; Kupsco A
    J Am Heart Assoc; 2022 Dec; 11(23):e026934. PubMed ID: 36382957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicoepigenetics and Environmental Health: Challenges and Opportunities.
    Svoboda LK; Perera BPU; Morgan RK; Polemi KM; Pan J; Dolinoy DC
    Chem Res Toxicol; 2022 Aug; 35(8):1293-1311. PubMed ID: 35876266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-synuclein overexpression induces epigenomic dysregulation of glutamate signaling and locomotor pathways.
    Schaffner SL; Wassouf Z; Lazaro DF; Xylaki M; Gladish N; Lin DTS; MacIsaac J; Ramadori K; Hentrich T; Schulze-Hentrich JM; Outeiro TF; Kobor MS
    Hum Mol Genet; 2022 Oct; 31(21):3694-3714. PubMed ID: 35567546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.